Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$127,561
in 3 filings, $17K under 10b5-1 plans

Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-08 Sanders Corazon (Corsee) D. Director Sale −1,485 $51.65 $77K 9,570
2023-06-07 Ray Amrit Director Grant or award +3,860 12,280
2023-06-07 Ray Amrit Director Grant or award · Stock Option (Right to Buy) +7,110 7,110
2023-06-07 Fust Matthew K Director Grant or award +3,860 30,355
2023-06-07 Fust Matthew K Director Returned to the company −3,300 $51.82 $171K 27,055
2023-06-07 Fust Matthew K Director Grant or award · Stock Option (Right to Buy) +7,110 7,110
2023-06-07 Sanders Corazon (Corsee) D. Director Grant or award +3,860 11,055
2023-06-07 Sanders Corazon (Corsee) D. Director Grant or award · Stock Option (Right to Buy) +7,110 7,110
2023-06-07 SULIMAN SHEHNAAZ Director Grant or award +3,860 14,855
2023-06-07 SULIMAN SHEHNAAZ Director Grant or award · Stock Option (Right to Buy) +7,110 7,110
2023-06-07 NARACHI MICHAEL Director Grant or award +3,860 21,605
2023-06-07 NARACHI MICHAEL Director Grant or award · Common Stock +7,110 7,110
2023-06-07 Dunsire Deborah Director Grant or award +3,860 19,730
2023-06-07 Dunsire Deborah Director Grant or award · Stock Option (Right to Buy) +7,110 7,110
2023-06-07 WELCH DANIEL G Director Grant or award +3,860 21,605
2023-06-07 WELCH DANIEL G Director Grant or award · Stock Option (Right to Buy) +7,110 7,110
2023-05-18 Pinion John Richard See Remarks Sale −2,012 $50.00 $101K 74,744
2023-05-09 Huizenga Theodore Alan SVP, Chief Accounting Officer Option exercise +3,000 $21.00 $63K 30,747
2023-05-09 Huizenga Theodore Alan SVP, Chief Accounting Officer Option exercise · Stock Option (Right to Buy) −3,000 5,000
2023-05-04 Parschauer Karah Herdman EVP and Chief Legal Officer Sale −4,378 $45.00 $197K 51,982

Page 12 of 21 · 410 trades